Synthesis of D- and L-myo-inositol 1,2,4,5-tetrakisphosphate and stereoselectivity of the I(1,4,5)P3 receptor binding

Bioorganic and Medicinal Chemistry Letters

Volumn 8, Issue 6, 1998, Pages 659-662

  Chung, Sung Kee ^a   Shin, Boo Gyo ^a   Chang, Young Tae ^a   Suh, Byung Chang ^a   Kim, Kyong Tai ^a  

^a Pohang University of Science and Technology (POSTECH)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; SUGAR ALCOHOL PHOSPHATE; CALCIUM CHANNEL; CELL RECEPTOR; INOSITOL 1,2,4,5 TETRAKISPHOSPHATE; INOSITOL PHOSPHATE; INOSITOL-1,2,4,5-TETRAKISPHOSPHATE;

ADRENAL CORTEX; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CATTLE; DIASTEREOISOMER; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; NONHUMAN; SECOND MESSENGER; STEREOCHEMISTRY; ANIMAL; CHEMICAL MODEL; CHO CELL; HAMSTER; METABOLISM; STEREOISOMERISM; SYNTHESIS;

ANIMALS; CALCIUM CHANNELS; CHO CELLS; CRICETINAE; INOSITOL PHOSPHATES; MODELS, CHEMICAL; RECEPTORS, CYTOPLASMIC AND NUCLEAR; STEREOISOMERISM;

EID: 0032539716     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(98)00081-X     Document Type: Article

References (25)

1. 1. a) Majerus, P. W. Annu. Rev. Biochem. 1992, 61, 225-250.
2. b) Berridge, M. J. Nature 1993, 361, 315-325
3. 2. Irvine, R. F.; Letcher, A. J.; Heslop, J. P.; Berridge, M. J. Nature 1986, 320, 631-634.
4. 3. Irvine, R. F.; Cullen, P. J. Current Biology 1993, 3, 540-543.
5. 4. Wilcocks, R. A.; Challiss, R. A. J.; Liu, C.; Potter, B. V. L.; Nahorski, S. R. Mol. Pharmacol. 1993, 44, 810-817.
6. 5. Chung, S. K.; Chang, Y. T. J. Chem. Soc., Chem. Commun. 1995, 11-12.
7. 6. Burford, N. T.; Nahorski, S. R.; Chung, S. K.; Chang, Y. T.; Wilcox, R. A. Cell Calcium 1997, 21, 301-304.
8. 7. a) Meek, J. L.; Davidson, F.; Hobbs, F. W. Jr. J. Am. Chem. Soc. 1988, 110, 2317-2318.
9. b) Carless, H. A. J.; Busia, K. Tetrahedron Lett. 1990, 31, 3449-3452.
10. 8. Chen, J.; Dorman, G.; Prestwich, G. D. J. Org. Chem. 1996, 61, 393-397.
11. 9. Kozikowski, A. P.; Fauq, A. H.; Wilcox, R. A.; Nahorski, S. R. Bioorg. Med. Chem. Lett. 1995, 5, 1295-1300.
12. 10. a) Mills, S. J.; Safrany, S. T.; Wilcox, R. A.; Nahorski, S. R.; Potter, B. V. L. Bioorg. Med. Chem. Lett. 1993, 3, 1505-1510.
13. b) Hirata, M; Narumoto, N.; Watanabe, Y.; Kanematsu, T.; Koga, T.; Ozaki, S. Mol. Pharmacol. 1994, 45, 271-276.
14. c) Wilcox, R. A.; Safrany, S. T.; Lampe, D.; Mills, S. J.; Nahorski, S. R.; Potter, B. V. L. Eur. J. Biochem. 1994, 223, 115-124.
15. 11. a) Polokoff, M. A.; Bencen, G. H.; Vacca, J. P.; DeSolms, S. J.; Young, S. D.; Huff, J. R. J. Biol. Chem. 1988, 263, 11922-11927.
16. b) Taylor, C. W.; Berridge, M. J.; Brown, K. D.; Cooke, A. M.; Potter, B. V. L. Biochem. Biophys. Res. Commun. 1988, 150, 626-632.
17. c) Strupish, J.; Cooke, A. M.; Potter, B. V. L.; Gigg, R.; Nahorski, S. R. Biochem. J. 1988, 253, 901-905.
18. 12. Chung, S. K.; Ryu, Y. Carbohydr. Res. 1994, 258, 145-167.
19. 2 = 1:7), 4D: 0.52; 4L: 0.44.
20. 14. The assignments of 4D and 4L were based on the literature data for 3L: Jones, M.; Rana, K. K.; Ward, J. G.; Young, R. C. Tetrahedron Lett. 1989, 30, 5353-5356.
21. 2).
22. 3OH).
23. 3) δ 0.70, 1.05 1.10, 1.61.
24. 2O, pH 10) δ 4.52, 5.06, 5.28, 5.37.
25. 19. Suh, B.-C.; Lee, C-O.; Kim, K.-T. J. Neurochem. 1995, 64, 1071-1079.